A Cost-effectiveness and Budget Impact Analysis of Fidaxomicin for Treating Clostridium Difficile Patients In Germany
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1357
https://www.valueinhealthjournal.com/article/S1098-3015(15)01414-X/fulltext
Title :
A Cost-effectiveness and Budget Impact Analysis of Fidaxomicin for Treating Clostridium Difficile Patients In Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01414-X&doi=10.1016/j.jval.2015.03.1357
First page :
A233
Section Title :
Infection
Open access? :
No
Section Order :
824